Skip to main content

Tarsus Pharmaceuticals, Inc 10-Q for FY2023 Q2

Tarsus Pharmaceuticals, Inc. (TARS)

10-Q 2023-08-10 For: 2023-06-30
View Original
Added on April 04, 2026

About this 10-Q

Tarsus Pharmaceuticals, Inc filed this 10-Q on August 10, 2023, covering the quarter ended June 30, 2023 (FY2023 Q2).

Headline figures

Quarter ended June 30, 2023, as reported in this filing, compared with the same period a year earlier where the filing states it.

Net loss
$31.42M
compared with a net loss of $5.74M a year earlier
Diluted EPS
-$1.17
compared with -$0.24 a year earlier